SMAD3 and neoplasm: For proneural GSCs, pharmacologic blockade of HIF-1α activity by GN44028 and of Smad3 activity by the Smad3 inhibitor, (E)-SIS3 or a palmitoylation inhibitor, 2-BP, effectively suppressed tumor growth and extended survival rates in animals with xenografts.